Christopher Watt serves as Executive at TETRAPHASE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christopher Watt has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 28, 2020 involved transacting 768.65 shares valued at $0.
Christopher Watt currently holds 21,782 shares of TETRAPHASE PHARMACEUTICALS INC (TTPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Watt has been a net neutral trader of TTPH stock. They have purchased $0 and sold $0 worth of shares.
Christopher Watt's most recent insider trade was on Jul 28, 2020, when they sold 768.65 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 14, 2018 | TTPH | $0 | Award | 3,332 | $N/A | Discretionary |
| May 14, 2018 | TTPH | $0 | Award | 2,058 | $N/A | Discretionary |